The Place of Screening in a National Cancer Strategy
National Lung Screening Trial
Ovarian Cancer Screening
Primary HPV Testing in a Canadian Organized Cervical Cancer Screening Program
The Added Value of Immunochemical FOBT Following a Negative Screening Sigmoidoscopy
Risk-based screening and overdiagnosis
Estimation of overdiagnosis by new technologies for cancer screening
Evidence and communication; understanding and communicating recommendations on mammography screening
Methodological approaches for the estimate of overdiagnosis in mammography screening: the cumulative incidence method and the Florence city (Italy) experience
Programme Types and Implementation Status of Cancer Screening in the European Union
Cost Effectiveness Analysis of Colorectal Cancer Screening Cessation in a Population of Patients with Chronic Illnesses
